May 10 (Reuters) - Gossamer Bio Inc GOSS.O :
* GOSSAMER BIO ANNOUNCES FIRST QUARTER 2022 FINANCIAL
RESULTS AND
PROVIDES BUSINESS UPDATE
* GOSSAMER BIO - SEES CURRENT CASH, CASH EQUIVALENTS,
MARKETABLE
SECURITIES, ACCESS TO DEBT FACILITY TO BE SUFFICIENT TO FUND
OPERATING & CAPEX INTO 2024
* QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.76
* Q1 EARNINGS PER SHARE VIEW $-0.77 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBwbqTbnza
Further company coverage: GOSS.O
((Reuters.Briefs@thomsonreuters.com;))